These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16806218)

  • 1. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.
    Wang YY; Luo J; Zhu MW; Liu LN; Ma X
    Int J Gynaecol Obstet; 2006 Jul; 94(1):67-72. PubMed ID: 16806218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies.
    Wan X; Wen J; Song X; Guo Y; Liu X; Yang B; Lu X
    Scand J Clin Lab Invest; 2012 Dec; 72(8):642-7. PubMed ID: 23057770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome validation of the Beckman Coulter access analyzer in a second-trimester Down syndrome serum screening application.
    MacRae AR; Gardner HA; Allen LC; Tokmakejian S; Lepage N
    Clin Chem; 2003 Jan; 49(1):69-76. PubMed ID: 12507962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
    Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
    Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.
    Xie Z; Lu S; Li H
    Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC; Wald NJ; Smith D; Kennard A; Densem J
    Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N; Densem J; Stone R; Cheng R
    Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
    Hsu JJ; Hsieh TT; Hsieh FJ
    Obstet Gynecol; 1996 Jun; 87(6):943-7. PubMed ID: 8649703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
    Hu Z; Liu X; Li L; Jia C; Li D; Liu R
    Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald N; Cuckle H; Wu TS; George L
    Br J Obstet Gynaecol; 1991 Sep; 98(9):905-8. PubMed ID: 1716981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD; McIntosh SF; Halstead AC
    Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P; Bischof P; Marguerat P; Mermillod B
    Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
    Wald NJ; Cuckle HS; Densem JW; Stone RB
    Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
    Cuckle HS; van Lith JM
    Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome.
    Kim SY; Kim SK; Lee JS; Kim IK; Lee K
    Yonsei Med J; 2000 Apr; 41(2):226-9. PubMed ID: 10817024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
    Palomaki GE; Knight GJ; Haddow JE
    Prenat Diagn; 1994 Jan; 14(1):65-8. PubMed ID: 7514290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.